Recently, the Delaware Chancery Court and the Third Circuit issued three significant decisions on key issues affecting licensing and M&A transactions in the life sciences industry....more
9/16/2024
/ Acquisitions ,
Breach of Contract ,
Commercially Reasonable Efforts ,
Due Diligence ,
Earn-Outs ,
IP License ,
Johnson & Johnson ,
Life Sciences ,
Medical Devices ,
Mergers ,
Patents ,
Pharmaceutical Industry ,
Royalties ,
Shareholders
In a much anticipated opinion, the U.S. Court of Appeals for the Ninth Circuit reversed a California district court decision holding that Qualcomm violated U.S. antitrust laws in its licensing of standard-essential patents in...more
8/12/2020
/ 5G Network ,
Anti-Competitive ,
Antitrust Provisions ,
Antitrust Violations ,
Appeals ,
Breach of Contract ,
Contract Disputes ,
Corporate Counsel ,
Exclusive Dealing Agreements ,
Federal Trade Commission (FTC) ,
FRAND ,
Intellectual Property Protection ,
IP License ,
Patents ,
Popular ,
Qualcomm ,
Royalties ,
Standard Essential Patents